-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DyuHwPFdjOuDkalvQ+XMa+KTJyEYkLy7xZWVGtDEg7HqwVYiF7L2TmRTGFKPsWJD VBH1E0h6EToItZXE/EPazQ== 0001005477-97-002352.txt : 19971020 0001005477-97-002352.hdr.sgml : 19971020 ACCESSION NUMBER: 0001005477-97-002352 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19971010 ITEM INFORMATION: FILED AS OF DATE: 19971017 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN PHARMACEUTICAL CO /DE CENTRAL INDEX KEY: 0000864494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841139559 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-24158 FILM NUMBER: 97697333 BUSINESS ADDRESS: STREET 1: 200 WEBRO RD CITY: PARSIPPANY STATE: NJ ZIP: 07054-2823 BUSINESS PHONE: 2015151000 FORMER COMPANY: FORMER CONFORMED NAME: BRASEL VENTURES INC DATE OF NAME CHANGE: 19930328 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ------------------------ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 October 10, 1997 ------------------------------ Date of Report AMERICAN PHARMACEUTICAL COMPANY ----------------------------------------- (Exact name of Registrant as Specified in Charter) DELAWARE 33-35153-D 84-1138558 - -------------------------------------------------------------------------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 12 DWIGHT PLACE FAIRFIELD, NEW JERSEY 07004 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (973)-276-1310 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) Item 5. Other Events On October 10, 1997, by unanimous written consent, the Directors of American Pharmaceutical Company extended to expiration date of the Company's Class B and Class C Warrants to April 30, 1998. The Company signed a lease and moved to occupy a 16,000 square foot building, for the executive offices, packaging operations and warehouse, located in an industrial park in Fairfield, New Jersey. The lease for the premises provides for rental payments in equal monthly installments of $7,333 until the expiration of the lease in September, 2002. In addition, the Company is required to pay all real estate taxes and utility expenses associated with the property. The lease may be renewed for another five year term upon its expiration. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed in its behalf by the undersigned thereunto duly authorized. AMERICAN PHARMACEUTICAL COMPANY DATED October 10, 1997 By: /s/ Christian M. Van Pelt -------------------------------------------- Christian M. Van Pelt, Chairman of the Board & Secretary DATED October 10, 1997 By: /s/ Alfred C. Bagwell -------------------------------------------- Alfred C. Bagwell, President & CEO -----END PRIVACY-ENHANCED MESSAGE-----